Publication

Serological biomarkers of tissue turnover can early identify responders to infliximab in Crohn's disease

van Haaften, W. T., Mortensen, J. H., Olesen, M. L., Karsdal, M. A., Olinga, P., Bay-Jensen, A. -C. & Dijkstra, G., 1-Feb-2017, In : Journal of Crohn's and Colitis. 11, p. S57-S57 1 p.

Research output: Contribution to journalMeeting AbstractAcademic

ID: 42705200